Dr. Ellen Morrison is the site lead and an investigator at the Bronx Prevention Center, a clinical research site that is one of the three sites that comprise the NIH-funded ICAP at Columbia Clinical Trials Unit. Dr. Morrison leads studies that focus on HIV prevention, including the use of pre-exposure prophylaxis and the provision of integrated services on a mobile van to engage out-of-care injection opiate users in HIV prevention and care. In addition, a rapid pivot to address the SARS-CoV-2 pandemic has included new projects on COVID-19 vaccines, testing of monoclonal antibodies, and other COVID-19 treatment modalities.
In addition, Dr. Morrison provides technical expertise in the areas of HIV treatment and prevention, tuberculosis, COVID-19 diagnosis and care, and other significant public health issues for ICAP programs, including projects in Sierra Leone, the Democratic Republic of the Congo, Central Asia, and Cameroon.
Dr. Morrison joined ICAP in 2018. However, she is a practicing board-certified Infectious disease physician who has been on the full-time faculty at the Columbia University Irving Medical Center for more than 25 years. Her career has focused on the care of underserved populations, clinical education, HIV testing and care, quality improvement, maternal infections, treatment of sexually transmitted infections, and the ethical review and conduct of clinical research.
Dr. Morrison received her medical degree from Washington University in St. Louis and received her MPH from the Mailman School of Public Health.